TY - JOUR
T1 - B cell-targeted immunotherapy for type 1 diabetes: What can make it work?
AU - Hamad, Abdel Rahim A.
AU - Ahmed, Rizwan
AU - Donner, Thomas
AU - Fousteri, Georgia
PY - 2016
Y1 - 2016
N2 - Immunotherapy has revolutionized treatment of cancers and autoimmune diseases. Bucking the trend, however, is type 1 diabetes (T1D), although it is one of best understood autoimmune diseases and individuals at genetic risk are identifiable with high certainty. Here we review the major obstacles associated with pan-B-cell-depletion using rituximab (RTX) and discuss the notion that B cell-directed therapy may be most effective as a preventive measure. We suggest that it will be more productive to aim at identifying and targeting autoreactive B cells rather than making adjustments to pan-B cell depletion and that non-conventional alternative therapies such as antibody blockade of FasL to bolster IL-10-producing Breg cells, which work successfully in mice, should be considered.
AB - Immunotherapy has revolutionized treatment of cancers and autoimmune diseases. Bucking the trend, however, is type 1 diabetes (T1D), although it is one of best understood autoimmune diseases and individuals at genetic risk are identifiable with high certainty. Here we review the major obstacles associated with pan-B-cell-depletion using rituximab (RTX) and discuss the notion that B cell-directed therapy may be most effective as a preventive measure. We suggest that it will be more productive to aim at identifying and targeting autoreactive B cells rather than making adjustments to pan-B cell depletion and that non-conventional alternative therapies such as antibody blockade of FasL to bolster IL-10-producing Breg cells, which work successfully in mice, should be considered.
UR - http://www.scopus.com/inward/record.url?scp=85007316346&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85007316346&partnerID=8YFLogxK
M3 - Article
VL - 21
SP - 213
EP - 219
JO - Discovery medicine
JF - Discovery medicine
SN - 1539-6509
IS - 115
ER -